UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000059953 |
|---|---|
| Receipt number | R000068577 |
| Scientific Title | Development and Efficacy of a Person-Centered Care-Based Metaverse Dementia Nursing Platform |
| Date of disclosure of the study information | 2025/12/10 |
| Last modified on | 2025/12/03 10:32:27 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Development and Efficacy of a Person-Centered Care-Based Metaverse Dementia Nursing Platform
Acronym
Development and Efficacy of a Person-Centered Care-Based Metaverse Dementia Nursing Platform
Scientific Title
Development and Efficacy of a Person-Centered Care-Based Metaverse Dementia Nursing Platform
Scientific Title:Acronym
Development and Efficacy of a Person-Centered Care-Based Metaverse Dementia Nursing Platform
Region
| Japan |
Condition
Condition
no
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to examine the efficacy of a Metaverse Dementia Nursing Platform (including elearning and video materials) based on person-centered care, utilizing the Metaverse a three dimensional digital virtual space where users enjoy interactive communication and activities via the internet and to evaluate its effectiveness, including educational program interventions.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
1. Attributes of research subjects
2. Metaverse experience
3. Program for developing dementia nursing practice skills to maintain the dignity of elderly individuals with dementia (including e-learning)
4. Frequency of use of the Dementia Practice Guide
5.Assessment of awareness regarding dementia nursing
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Other |
Interventions/Control_1
Metaverse Dementia Nursing Platform Based on Person-Centered Care Using the Metaverse (e-learning, video materials, etc.)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 60 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Target patients meeting all the following criteria:
1. All full-time nurses (approximately 700) at Juntendo University Shizuoka Hospital (633 beds: 7:1 nursing ratio)
2.Those involved in the treatment and nursing care of elderly dementia patients
3.Individuals for whom informed consent to participate in this research, given of their own free will, has been obtained
4.Individuals able to connect to the internet via their personal PC and acc
Key exclusion criteria
The following individuals shall not be included in this study:
1. Professionals from hospitals other than the designated study hospital
2. Professionals not involved in the treatment or care of elderly individuals with dementia
3. Individuals working part-time, on maternity leave, or on leave of absence
4. Individuals for whom research participation consent could not be obtained
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | mizue |
| Middle name | |
| Last name | Suzuki |
Organization
Hamamatsu University, Faculty of Nursing,
Division name
Hamamatsu University, Faculty of Nursing,
Zip code
431-3192
Address
Handayama Hamamatsu Shizuoka
TEL
0534352826
mizuesuzuki@gmail.com
Public contact
Name of contact person
| 1st name | mizue |
| Middle name | |
| Last name | Suzuki |
Organization
Hamamatsu University School of Medicine
Division name
Faculty of Nursing
Zip code
431-3192
Address
Handayama 1-20-1
TEL
0534352826
Homepage URL
mizuesuzuki@gmail.com
Sponsor or person
Institute
Hamamatsu University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Hamamatsu University School of Medicine
Organization
Division
Category of Funding Organization
Government offices of other countries
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Hamamatsu University School of Medicine
Address
Handayama 1-20-1
Tel
0534352826
m~suzuki@hama-med.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 12 | Month | 10 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 08 | Month | 01 | Day |
Date of IRB
| 2025 | Year | 08 | Month | 21 | Day |
Anticipated trial start date
| 2025 | Year | 12 | Month | 01 | Day |
Last follow-up date
| 2026 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 12 | Month | 03 | Day |
Last modified on
| 2025 | Year | 12 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068577
